(Q22305943)

PubMed

7 February 2023

Elizabeth D Barnett

1

Elizabeth D

Barnett

1 reference

PubMed

7 February 2023

Mary E Wilson

3

Mary E

Wilson

1 reference

PubMed

18564013

Expert Review of Vaccines

7 February 2023

language of work or name

English

0 references

publication date

July 2008

0 references

published in

0 references

volume

7

0 references

issue

5

0 references

page(s)

579-587

0 references

cites work

Prevention of yellow fever in persons traveling to the tropics

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Yellow fever: a decade of reemergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Yellow Fever Immunizations: Indications and Risks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Yellow fever: epidemiology and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Pathogenesis and pathophysiology of yellow fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Urban yellow fever epidemic in western Nigeria, 1987.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Neurological adverse events temporally associated to mass vaccination against yellow fever in Juiz de Fora, Brazil, 1999-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Immune response during adverse events after 17D-derived yellow fever vaccination in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Advanced Age a Risk Factor for Illness Temporally Associated with Yellow Fever Vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Yellow fever 17D vaccine safety and immunogenicity in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

History of thymoma and yellow fever vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Congenital arboviral infections: something new, something old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Yellow fever vaccination during pregnancy and spontaneous abortion: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Yellow fever vaccination and pregnancy: a four-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

The revised international health regulations and their relevance to travel medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

First recorded outbreak of yellow fever in Kenya, 1992-1993. I. Epidemiologic investigations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

inferred from DOI database lookup

7 January 2021

based on heuristic

The revised International Health Regulations (2005): impact on yellow fever vaccination in clinical practice.

1 reference

https://api.crossref.org/works/10.1586%2F14760584.7.5.579

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1586/14760584.7.5.579

0 references